MHRA Drug Safety Update May 2022

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 15 Issue 10 May 2022) has been published and includes articles on:

  • Denosumab 60mg (Prolia): should not be used in patients under 18 years due to the risk of serious hypercalcaemia
  • COVID-19 vaccines and medicines: updates for May 2022
  • Letters and medicine recalls sent to healthcare professionals in April 2022

To see the latest MHRA Drug Safety Updates in full, visit the website

Guiding pharmacy owners and their teams on the journey to start providing the new Pharmacy First service, and the updated Contraception and Hypertension Case-Finding Services.

Click Here